North America Animal Biotechnology Market Size & Outlook

The animal biotechnology market in North America is expected to reach a projected revenue of US$ 17,217.2 million by 2030. A compound annual growth rate of 9.3% is expected of North America animal biotechnology market from 2023 to 2030.
Revenue, 2022 (US$M)
$8,446.5
Forecast, 2030 (US$M)
$17,217.2
CAGR, 2023 - 2030
9.3%
Report Coverage
North America

North America animal biotechnology market, 2018-2030 (US$M)

North

North America animal biotechnology market highlights

  • The North America animal biotechnology market generated a revenue of USD 8,446.5 million in 2022.
  • The market is expected to grow at a CAGR of 9.3% from 2023 to 2030.
  • In terms of segment, diagnostics tests was the largest revenue generating product in 2022.
  • Diagnostics Tests is the most lucrative product segment registering the fastest growth during the forecast period.

North America data book summary

Market revenue in 2022USD 8,446.5 million
Market revenue in 2030USD 17,217.2 million
Growth rate9.3% (CAGR from 2022 to 2030)
Largest segmentDiagnostics tests
Fastest growing segmentDiagnostics Tests
Historical data covered2018 - 2021
Base year for estimation2022
Forecast period covered2023 - 2030
Quantitative unitsRevenue in USD million
Market segmentationDiagnostics Tests
Key market players worldwideZoetis Inc Class A, Boehringer Ingelheim, Biogenesis Bago, Merck & Co Inc, Virbac SA, Elanco Animal Health Inc, IDEXX Laboratories Inc, HESKA, Indian Immunologicals, Hester Biosciences, Kareo, NXGN

Other key industry trends

  • In terms of revenue, North America region accounted for 35.6% of the global animal biotechnology market in 2022.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 11,634.1 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Animal Biotechnology Market Scope

Animal biotechnology market segmentation & scope
Diagnostics Tests
Vaccines
Drugs
Reproductive And Genetic
Feed Additives
Application
Diagnosis of Animal Diseases
Treatment of Animal Diseases
Preventive Care of Animals
Drug Development
Others
Animal Type
Livestock
Poultry
Swine
Cattle
Sheep & Goats
Fish
Companion
Dogs
Cats
Horses
Others
End Use
Laboratories
Point-of-care testing/In-house testing
Veterinary Hospitals & Clinics
Others

Animal Biotechnology Market Companies

Name Profile # Employees HQ Website

North America animal biotechnology market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to animal biotechnology market will help companies and investors design strategic landscapes.


Diagnostics tests was the largest segment with a revenue share of 100% in 2022. Horizon Databook has segmented the North America animal biotechnology market based on diagnostics tests covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to North America animal biotechnology market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of North America animal biotechnology market databook

  • Our clientele includes a mix of animal biotechnology market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the North America animal biotechnology market, including forecasts for subscribers. This continent databook contains high-level insights into North America animal biotechnology market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

North America animal biotechnology market

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more